You can't measure a bio company in days and weeks - that's daft.
Ask yourself these questions:
• do they have products that works?
• do they need to go through steps to become commercialised?
• can they magically accelerate through those steps with a better CEO? Perhaps by giving cattle prods to the lab folk?
• are they on the brink of first sales?
• Is there another wow product just a few months behind?
My approach is to see what this year brings - review in December
IIQ General Discussion, page-169
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.010(1.75%) |
Mkt cap ! $59.09M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 54.0¢ | $96.73K | 176.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 7999 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |